European Commission approves Pfizer's RSV vaccine for adults at increased risk of disease
The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...
Pfizer Gets Expanded European Approval of Abrysvo RSV Vaccine for All Adults
Pfizer has won European Commission expanded approval of its Abrysvo vaccine for respiratory syncytial virus, or RSV, for use in all adults. The New York drugmaker on Tuesday said the extended ...
Did Pfizer Delay Covid Vaccine Announcement Until After 2020 Election? Here’s What We Know.
Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.
Feds probe disputed tip Pfizer held Covid vaccine results until after 2020 vote: WSJ
President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.
Feds probe tip that Pfizer delayed announcing COVID vaccine’s success until after 2020 election: report
The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...
European Commission Approves Pfizer’s RSV Vaccine ABRYSVO® to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...
Explore more
U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine
The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...
US prosecutors probe tip about timing of Pfizer's COVID vaccine, WSJ reports
(Reuters) -Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's ...
US FDA approves freeze-dried version of Bavarian Nordic's mpox, smallpox vaccine
Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its ...
Pfizer Stock (PFE) Slips as U.S. Probes the Timing of Its COVID-19 Vaccine Results
Pfizer (PFE) shares slipped on Wednesday after The Wall Street Journal reported that U.S. authorities are investigating ...
Pfizer Stock Slips After Report on Vaccine Timing Probe
Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion ...
Fierce Pharma4d
GSK tip claiming Pfizer delayed COVID vaccine results during 2020 election prompts US probe: WSJ
Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...